Skip to Content

Terumo Group

News

Showing 1 to 9 of 54

May 27

Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System

May 27, 2025
Apr 16

Terumo Health Outcomes Now Offers FDA-Cleared Medis QFR® 3.0 Software for Coronary Physiology Assessment in the US

Apr 16, 2025
Dec 10

Terumo Health Outcomes and Medis Medical Imaging Announce Strategic Partnership to Enhance Cardiovascular Care

Dec 10, 2024
Dec 3

Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter

Dec 03, 2024
Feb 14

Terumo Medical Corporation Breaks Ground on New Manufacturing Site at Its Puerto Rico Location

Feb 14, 2024
Dec 11

Terumo Medical Corporation’s New AZUR HydroPack™ Peripheral Coil System Provides a Soft-Packing, Long-Lasting Solution to Embolotherapy

Dec 11, 2023
Apr 24

Terumo Group’s Targets for Greenhouse Gas Reduction Approved by the SBT Initiative as 1.5°C Aligned

Apr 24, 2023
Mar 20

Prospective, Multi-Center, Single-Arm Study Demonstrates Effectiveness of Terumo Medical Corporation’s Cross-Seal™ Suture-Mediated Vascular Closure Device (VCD) System

Mar 20, 2023
Nov 1

New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography

Nov 01, 2022

Showing 1 to 9 of 54